MDxHealth S.A.
MXDHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.06 | 0.06 | -0.14 | 0.13 |
| FCF Yield | -17.94% | -25.97% | -36.50% | -20.20% |
| EV / EBITDA | -5.84 | -3.97 | -3.55 | -3.04 |
| Quality | ||||
| ROIC | -21.46% | -24.46% | -36.92% | -41.99% |
| Gross Margin | 61.23% | 62.58% | 51.87% | 47.50% |
| Cash Conversion Ratio | 0.75 | 0.79 | 0.90 | 0.84 |
| Growth | ||||
| Revenue 3-Year CAGR | 34.45% | 46.69% | 26.14% | 23.57% |
| Free Cash Flow Growth | 21.98% | 30.73% | -63.29% | -12.81% |
| Safety | ||||
| Net Debt / EBITDA | -0.60 | -0.62 | -0.67 | 1.78 |
| Interest Coverage | -3.24 | -4.73 | -13.82 | -14.32 |
| Efficiency | ||||
| Inventory Turnover | 9.02 | 9.45 | 7.66 | 6.11 |
| Cash Conversion Cycle | 15.70 | -25.22 | -68.50 | -98.12 |